
HGH
$35
In stock
View productThis category holds the growth hormone compounds in our catalog, including HGH, Tesamorelin, CJC-1295, Ipamorelin, GHRP-2, GHRP-6 and AOD-9604, each labeled for research use only and shipped from the USA and Canada to addresses across the United States.
Most products here belong to one group on the World Anti-Doping Agency's 2026 Prohibited List: growth hormone releasing factors, which the list says include CJC-1295, tesamorelin, ipamorelin, GHRP-2 and GHRP-6.1 The class is banned in sport at all times.1 FDA's compounding lists treat the same compounds in different ways:
HGH and the KLOW blend also appear in several other categories. For the two growth hormone releasing peptides, start with What is GHRP-2? and What is GHRP-6?.

$35
In stock
View product
From $30
In stock
Choose strength
$95
In stock
View product
$25
In stock
View product
$30
In stock
View product
$30
In stock
View product
$30
In stock
View product
$40
In stock
View product
$75
In stock
View productNo products match these filters.
Orders for these vials ship from the USA and Canada to addresses across the United States; the shipping page has the delivery details. Return terms are on the returns page, and testing documents are listed on the lab results page as they become available. The reconstitution calculator works out vial concentrations, and insulin syringes are sold separately.
No source on this page ranks them; what separates them is what FDA has recorded about safety. FDA notes serious adverse events with CJC-1295, including increased heart rate and a systemic vasodilatory reaction, and calls the clinical data limited.2 For ipamorelin, FDA cites a published study that identified serious adverse events, including death, when ipamorelin was given intravenously to improve gastric motility.2 Compare the education pages for CJC-1295 with DAC, Ipamorelin and Tesamorelin before choosing a compound for a study.
FDA says it has identified no or only limited safety information for AOD-9604, and also serious adverse events that may be associated with it, though causality is not clear.2 AOD-9604 was once in FDA's Category 2 for compounding, the group with significant safety concerns, before its nominations were withdrawn.2 In sport, WADA's 2026 list bans it at all times as a growth hormone fragment.1 More is on What is AOD-9604?.
No. WADA's 2026 Prohibited List classes sermorelin as a growth hormone releasing factor, in the same group as CJC-1295 and tesamorelin, not as growth hormone.1 Sermorelin is not filed in this category. It has its own product page, Sermorelin, as does the CJC-1295 + Ipamorelin blend. For the hormone itself, see What is HGH?.
D2C Peptides sells peptides for laboratory research. Please confirm both statements to continue.